Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
04 févr. 2016 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
22 janv. 2016 09h16 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Present at Noble Financial Capital Markets’ Twelfth Annual Equity Conference
15 janv. 2016 16h31 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey’s Technology Business Tax Certificate Transfer Program
01 déc. 2015 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a specialty pharmaceutical company focused on the development and commercialization of new prescription...
Agile Therapeutics Reports Third Quarter Financial Results
09 nov. 2015 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
![WCG logo](/news-release/logo/358858/0/358858.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A26&size=2)
The Population Council and WomanCare Global Announce Worldwide License Agreement to Advance Women's Access to Innovative Contraceptive Ring
04 nov. 2015 09h15 HE
|
WomanCare Global
NEW YORK and SAN DIEGO, Nov. 4, 2015 (GLOBE NEWSWIRE) -- In a major step forward for women's health, the Population Council and WomanCare Global (WCG) today announced an exclusive worldwide licensing...
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
19 oct. 2015 16h08 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Participate at FBR Second Annual Healthcare Conference
03 sept. 2015 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial
31 août 2015 16h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...
![Reacts to lawsuit ruling](http://www.globenewswire.com/fr/Attachment/LogoDisplay/302159?filename=302159.jpg&size=2)
EWTN Denied Protection Against Contraception Mandate
17 juin 2014 20h15 HE
|
EWTN Global Catholic Network
Irondale, AL, June 17, 2014 (GLOBE NEWSWIRE) -- U.S. District Court Judge Callie V.S. Granade of Mobile, Ala.
issued an opinion on June 17 denying EWTN Global Catholic Network
protection from the...